Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1913 1
1936 1
1939 2
1940 1
1941 1
1944 1
1945 2
1946 9
1947 6
1948 8
1949 9
1950 6
1951 17
1952 12
1953 19
1954 18
1955 17
1956 11
1957 11
1958 21
1959 17
1960 15
1961 15
1962 17
1963 21
1964 25
1965 18
1966 10
1967 6
1968 13
1969 7
1970 14
1971 21
1972 13
1973 17
1974 18
1975 46
1976 53
1977 57
1978 67
1979 104
1980 115
1981 165
1982 272
1983 328
1984 431
1985 627
1986 832
1987 880
1988 1003
1989 1385
1990 1416
1991 1517
1992 1625
1993 1722
1994 2131
1995 2172
1996 2536
1997 2755
1998 2893
1999 2942
2000 3397
2001 3495
2002 3781
2003 3853
2004 4540
2005 4878
2006 5346
2007 5489
2008 5870
2009 6352
2010 7297
2011 7776
2012 8708
2013 9313
2014 10168
2015 10702
2016 11228
2017 11976
2018 12574
2019 13376
2020 15404
2021 8567
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

183,509 results
Results by year
Filters applied: . Clear all
Page 1
Mouse Models of Alzheimer's Disease.
Esquerda-Canals G, Montoliu-Gaya L, Güell-Bosch J, Villegas S. Esquerda-Canals G, et al. J Alzheimers Dis. 2017;57(4):1171-1183. doi: 10.3233/JAD-170045. J Alzheimers Dis. 2017. PMID: 28304309 Review.
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide and it is predicted to exponentially increase in the coming decades. Because no curative treatment exists, research on the pathophysiology of
Alzheimer's disease (AD) is a neurodegenerative disorder that nowadays affects more than 40 million people worldwide an
Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
Calsolaro V, Edison P. Calsolaro V, et al. Alzheimers Dement. 2016 Jun;12(6):719-32. doi: 10.1016/j.jalz.2016.02.010. Epub 2016 May 11. Alzheimers Dement. 2016. PMID: 27179961 Review.
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing results. ...In this review, we focus on the potential mechanism of glial activation and how local and systemic factors influence disease
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing resu …
Neuropsychiatric symptoms in Alzheimer's disease.
Lyketsos CG, Carrillo MC, Ryan JM, Khachaturian AS, Trzepacz P, Amatniek J, Cedarbaum J, Brashear R, Miller DS. Lyketsos CG, et al. Alzheimers Dement. 2011 Sep;7(5):532-9. doi: 10.1016/j.jalz.2011.05.2410. Alzheimers Dement. 2011. PMID: 21889116 Free PMC article.
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge primarily in people with late-stage disease, these symptoms are currently known to manifest commonly in very early disease and …
Neuropsychiatric symptoms (NPS) are core features of Alzheimer's disease and related dementias. Once thought to emerge …
Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.
Hane FT, Robinson M, Lee BY, Bai O, Leonenko Z, Albert MS. Hane FT, et al. J Alzheimers Dis. 2017;57(3):645-665. doi: 10.3233/JAD-160907. J Alzheimers Dis. 2017. PMID: 28269772 Free PMC article. Review.
The field of Alzheimer's disease (AD) research has grown exponentially over the past few decades, especially since the isolation and identification of amyloid-beta from postmortem examination of the brains of AD patients. Recently, the Journal of Alzheimer
The field of Alzheimer's disease (AD) research has grown exponentially over the past few decades, especially since the …
Biomarkers for preclinical Alzheimer's disease.
Tan CC, Yu JT, Tan L. Tan CC, et al. J Alzheimers Dis. 2014;42(4):1051-69. doi: 10.3233/JAD-140843. J Alzheimers Dis. 2014. PMID: 25024325 Review.
Currently, there is a pressing need to shift the focus to accurate detection of the earliest phase of increasingly preclinical Alzheimer's disease (AD). Meanwhile, the growing recognition that the pathophysiological process of AD begins many years prior to cl …
Currently, there is a pressing need to shift the focus to accurate detection of the earliest phase of increasingly preclinical Alzheimer
Female Sex and Alzheimer's Risk: The Menopause Connection.
Scheyer O, Rahman A, Hristov H, Berkowitz C, Isaacson RS, Diaz Brinton R, Mosconi L. Scheyer O, et al. J Prev Alzheimers Dis. 2018;5(4):225-230. doi: 10.14283/jpad.2018.34. J Prev Alzheimers Dis. 2018. PMID: 30298180 Free PMC article. Review.
Along with advanced age and apolipoprotein E (APOE)-4 genotype, female sex is a major risk factor for developing late-onset Alzheimer's disease (AD). Considering that AD pathology begins decades prior to clinical symptoms, the higher risk in women cannot simp …
Along with advanced age and apolipoprotein E (APOE)-4 genotype, female sex is a major risk factor for developing late-onset Alzheimer
Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.
Robinson M, Lee BY, Hane FT. Robinson M, et al. J Alzheimers Dis. 2017;57(2):317-330. doi: 10.3233/JAD-161149. J Alzheimers Dis. 2017. PMID: 28211812 Free PMC article. Review.
This is the second part of a three-part review series reviewing the most important advances in Alzheimer's disease (AD) research since 2010. This review covers the latest research on genetics and epidemiology. ...
This is the second part of a three-part review series reviewing the most important advances in Alzheimer's disease (AD) …
Art therapy for Alzheimer's disease and other dementias.
Chancellor B, Duncan A, Chatterjee A. Chancellor B, et al. J Alzheimers Dis. 2014;39(1):1-11. doi: 10.3233/JAD-131295. J Alzheimers Dis. 2014. PMID: 24121964 Review.
We offer a theoretical framework that motivates the use of art therapy and propose that clinical enquiry to establish methods, assess efficacy, and define optimal conditions for the use of art therapy in Alzheimer's and other dementing disorders is timely....
We offer a theoretical framework that motivates the use of art therapy and propose that clinical enquiry to establish methods, assess effica …
The Mechanisms of Action of Curcumin in Alzheimer's Disease.
Tang M, Taghibiglou C. Tang M, et al. J Alzheimers Dis. 2017;58(4):1003-1016. doi: 10.3233/JAD-170188. J Alzheimers Dis. 2017. PMID: 28527218 Review.
Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. As the prevalence of AD rises in the 21st century, there is an urgent need for the development of effective pharmacotherapies. Currently, drug treatments target the symptoms of the di
Alzheimer's disease (AD) is a neurodegenerative disorder of the elderly. As the prevalence of AD rises in the 21st cent
Is Alzheimer's Disease Risk Modifiable?
Serrano-Pozo A, Growdon JH. Serrano-Pozo A, et al. J Alzheimers Dis. 2019;67(3):795-819. doi: 10.3233/JAD181028. J Alzheimers Dis. 2019. PMID: 30776012 Free PMC article. Review.
Population-based clinic-pathological studies have established that the most common pathological substrate of dementia in community-dwelling elderly people is mixed, especially Alzheimer's disease (AD) and cerebrovascular ischemic disease (CVID), rather …
Population-based clinic-pathological studies have established that the most common pathological substrate of dementia in community-dwelling …
183,509 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page